Rotella Capital Management’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

Rotella Capital Management’s Portfolio ENZN Stock Details ENZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-64,910	Closed	-$78K	–	742
2015 Q2	$78K	Buy	64,910 +11,020	+20%	+$14K	0.06%	313
2015 Q1	$57K	Buy	53,890 +16,926	+46%	+$17.5K	0.05%	443
2014 Q4	$40K	Sell	36,964 -16,188	-30%	-$17K	0.03%	316
2014 Q3	$57K	Buy	+53,152	New	+$65.6K	0.06%	235
2014 Q1	–	Sell	-13,701	Closed	-$16K	–	284
2013 Q4	$16K	Buy	13,701 +1,368	+11%	+$2.11K	0.03%	96
2013 Q3	$21K	Sell	12,333 -13,209	-52%	-$24.4K	0.04%	123
2013 Q2	$51K	Buy	+25,542	New	+$74.8K	0.16%	83

Other funds holding ENZN

Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return

Rotella Capital Management's ENZN Position: Q3 2015 in Review

Rotella Capital Management sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q3 2015, closing a stake of 64,910 shares — an estimated $78K sold.

Rotella Capital Management first reported a position in ENZN in Q2 2013 and held it in 7 quarters. The position peaked at $78K in Q2 2015. 53 funds tracked by Wall St. Rank hold ENZN as of Q3 2015.

Rotella Capital Management reported no remaining ENZON PHARMACEUTICALS INC position as of Q3 2015 after selling out during the quarter.
Rotella Capital Management sold 64,910 ENZON PHARMACEUTICALS INC shares in Q3 2015, an estimated $78K.
Rotella Capital Management first reported a position in ENZON PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
Rotella Capital Management's ENZON PHARMACEUTICALS INC position peaked at $78K in Q2 2015.
53 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q3 2015.

Based on Rotella Capital Management's 13F filing for Q3 2015, filed 13 Nov 2015.